Hatice DÜLEK, Zeynep TUZCULAR VURAL, Işık GÖNENÇ

Kardiyovasküler Hastalıklara Etki Eden Faktörlerin Değerlendirilmesi ve Kardiyovasküler Risk Skorlamalarının Karşılaştırılması

Amaç: Bu çalışmada; 40 yaş üstü bireylerde kardiyovasküler hastalıklara etki eden faktörlerin değerlendirilmesi için kardiyovasküler risk skorlamalarının (Framingham, PooledCohort Risk Assesment Equations; PCRAE), antropometrik ölçümlerin hesaplanması, yüksek riskli hastaları belirleyebilme güçlerinin karşılaştırılması amaçlanmıştır. Yöntemler: Çalışma; Eğitim ve Araştırma Hastanesi’nde, Aile Hekimliği polikliniğine başvuran, 40-72 yaş aralığında 258 hasta ile yapıldı. Analizler için Number Cruncher Statistical System 2007 programı kullanıldı. Bulgular: Framingham ve PCRAE skoru, yüksek risk düzeyinde olan olguların yaşları, erkek cinsiyet olması, bel/kalça çevresi oranı; düşük risk düzeyinde olan olgulara göre istatistiksel olarak anlamlı düzeyde yüksek saptanmıştır (p

Evaluation of Risk Factors Influencing Cardiovascular Disease and Correlation with Cardiovascular Risk Scores

Objective: In this study, we aimed to evaluate cardiovascular risk scores (Framingham, Pooled Cohort Risk Assessment Equations; PCRAE), anthropometric measurements and compare their strengths for identifying patients at high risk for cardiovascular disease in individuals over the age of 40. Method: This study was performed with 258 patients aged 40 to 72 years meeting the eligibility criteria for the study who admitted to the Family Practice Centers of Training and Research Hospital. Number Cruncher Statistical System 2007 Statistical software was used for the statistical analysis. Results: Age, male gender, waist-to-hip ratio of patients with high Framingham and PCRAE risk scores were determined to be statistically significantly higher than patients with low Framingham and PCRAE risk scores (p

PDF

___

1. WHO. Cardiovasculer diseases. Fact sheet Update May 2017-06-21 Ulaşılabileceği adres: http://www.who.int/mediacentre/factsheets/fs317/en/
2. World Health Organization. The global burden of disease: 2004 Update. Geneva: World Health Organization; 2008. Ulaşılabileceği adres: http://www.who.int/healthinfo/global_burdendisease/2004_report_update/en.
3. Chehrei A, Sadrnia S, Keshteli AH, Danashmand MA, Rezaei J. Correlation of dyslipidemi a with waist to height ratio, waist circumference and body mass index in Iranian adults. Asia Pac J Clin Nutr. 2007; 16: 248-53.
4. Patel S, Unwin N, Bhopol R, et all. A comparison of Chinese, European and South Asian adults. Diabet Med. 1999; 16: 853-60.
5. Larsson B. Fat distribution during growth and ater health outcomes. In: Bouchard C, Johnston FE. Current topics in nutrition and disease, 17 th. de. Edn. New York: Alan R. Liss, 1988: 193-201.
6. World Health Organization. Waist circumference and waist-hipratio: Report of a WHO expert consultation, Geneva, 8-11 December 2008. Ulaşılabileceği adres: https://www.who.int/nutrition/publications/obesity/ WHO_report_waistcircumference_and_waisthip_ratio/e /
7. Ben-Noun L, Laor A. Relation ship of neck circumference to cardiovascular risk factors. ObesRes. 2003; 11: 226-31.
8. Matheny M, McPheeters MI, Glasser A, et all. Systematic review of cardiovascular disease risk assessment tools (Internet). 2011;Rep no11-05155-EF1.
9. Gardner AW, Afaq A. Management of lower extremity peripheral arterial disease. J Cardio pulm Rehabil Prev. 2008; 28: 349-57.
10. Hambrecht R, Wolf A, Gielen S, et all. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Eng J Med. 2000; 342: 454- 60.
11. Banegas JR, López-García E, Dallongeville J, et all. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. EurHeart J. 2011; 32: 2143- 52.
12. Abacı A. Kardiyovasküler risk faktörlerinin ülkemizdeki durumu, Türk Kardiyol Dern Arş – Arch Turk Soc Cardiol. 2011;39 Suppl4: 1-5.
13. Tokgözoğlu L, Kaya EB, Erol C, Ergene O; EUROASPIRE III Turkey Study Group. EUROASPIRE III: A comparison between Turkey and Europe. Türk Kardiyol Dern Arş. 2010;38: 164-72.
14. Sağıroğlu M. Birinci basamak sağlık kuruluşuna başvuran 30 yaş ve üzeri bireylerde kardiyovasküler risk faktörleri ve yaşam kalitesi ilişkisi (tez). Kayseri: Erciyes Üniversitesi; 2014.
15. World Health Organization. Reducing risks, promoting healthy life. The World health report 2002. Ulaşılabileceği adres: https://www.who.int/whr/2002/en/
16. Preis SR, Hwang SJ, Coady S, et all. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in theFramingham Heart Study, 1950 to 2005. Circulation. 2009;119(13):1728-35.
17. Satman I, Omer B, Tutuncu Y, et all. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiology. 2013; 28: 169-80.
18. Türkiye Diyabet, Hipertansiyon, Obezite ve Endokrinolojik Hastalıklar Prevalans Çalışması II (TURDEP II) sonuçlarının özeti. Ulaşılabileceği adres: http://www.istanbul.edu.tr/itf/ attachments/021_turdep.2.sonuclarinin.aciklamasi.pdf
19. Wilson K, Gibson N, Willan A, Cook D. Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies. Arch Intern Med. 2000; 160: 939-44.
20. Savji N, Rockman CB, Skolnick AH, et all. Association between advanced age and vascular disease in different arterial territories: a population data base of over 3.6 million subjects. J Am Coll Cardiol. 2013; 61: 1736-43.
21. Finegold JA, Asaria P, Francis DP. Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations. International journal of cardiology. 2013; 168: 934–45.
22. Kappert K, Böhm M, Schmieder R, et all. Impact of sex on cardiovascular outcome in patients at high cardiovascular risk: Analysis of the Telmisartan Randomized Assessment Study in ACE-Intolerant Subjects With Cardiovascular Disease (TRANSCEND) and the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial (ONTARGET). Circulation. 2012; 126: 934-41.
23. Türkiye Beden Ağırlığı Algısı Araştırması, T.C Sağlık Bakanlığı, Sağlığın Geliştirilmesi Genel Müdürlüğü, Ankara. Yayın no: 894, 2012; sf:14 Ulaşılabileceği adres: https://sbu.saglik.gov.tr/Ekutuphane/kitaplar/bedenagir_tr.pdf
24. Jensen MD, Ryan DH, Apovian CM, et all. 2013 AHA/ACC/TOS guideline for the management of over weight and obesity in adults: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014; 129: 102 -38.
25. Niedereuar CM, Binkley TL. Effect of truncal adiposity on plasma lipid and lipoprotein concentrations. J Nutr Health Aging. 2006; 10: 154-60.
26. Lee ZSK, Critchley JAJH, Ko GTC, et all. Obesity and cardiovascular risk factors in Hong Kong Chinese. Obes Rev. 2002;3: 173-82.
27. Canoy D, Wareham N, Luben R, et all. Serum lipid concentration in relation to anthropometric indices of central and peripheral fat distributionin 20,021 British men and women: results from the EPIC-Norfolk population-based cohort study. Atherosclerosis. 2006 Dec; 189: 420-7.
28. Esmaillzadeh A, Mirmiran P, Azizi F. Waist-to-hip ratio is a beter screening measure for cardiovasculer risk factors than other anthropometric indicators in Tehranian adult men. Int J Obes Relat Metab Disord. 2004; 28: 1325-32.
29. Fox K, Garcia MA, Ardissino D, et all. Guidelines on the management of stable angına pectoris: executive summary: the task force on the management of stable angına pectoris of theEurope an society of cardiology. EurHeart J. 2006; 27: 1341–81.